acetyleugenol has been researched along with Leishmaniasis, Visceral in 2 studies
*Leishmaniasis, Visceral: A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bevilaqua, CM; Campello, CC; de Alencar Araripe Noronha Moura, A; de Andrade, HF; de Figuereido, JR; de Morais, SM; Lobo, CH; Rodrigues, AP; Rondon, FC; Sales, AD; Vila-Nova, NS; Wilson, ME | 1 |
| Charan Raja, MR; Chellappan, D; Debnath, J; Kar Mahapatra, S; Velappan, AB | 1 |
2 other study(ies) available for acetyleugenol and Leishmaniasis, Visceral
| Article | Year |
|---|---|
Thymol and eugenol derivatives as potential antileishmanial agents.
Topics: Animals; Antiprotozoal Agents; Cell Line; Eugenol; Humans; Leishmania infantum; Leishmaniasis, Visceral; Macrophages; Male; Mice; Mice, Inbred BALB C; Thymol | 2014 |
Eugenol derived immunomodulatory molecules against visceral leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Cell Survival; Dose-Response Relationship, Drug; Eugenol; Immunomodulation; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Male; Mice; Mice, Inbred BALB C; Molecular Structure; Parasitic Sensitivity Tests; RAW 264.7 Cells; Structure-Activity Relationship | 2017 |